Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ambroxol by Belrose Pharma for Gaucher Disease Type I: Likelihood of Approval
Ambroxol is under clinical development by Belrose Pharma and currently in Phase II for Gaucher Disease Type I. According to...